Our effective tax rate for the three months ended June 30, 2018 increased to 46% from 38% for the three months ended June 30, 2017.
Our effective tax rate for the six months ended June 30, 2018 decreased to 34% from 55% for the six months ended June 30, 2017.
From time to time, the Company is involved in routine litigation that arises in the ordinary course of business.
From time to time, we are involved in routine litigation that arises in the ordinary course of business.
The SSP of hardware is cost plus a reasonable margin.
The awards provide for an aggregate target of 184,776 shares, none of which have been included in the calculation of diluted EPS for the three and six months ended June 30, 2018 because the related threshold award performance level has not been achieved as of June 30, 2018.
During the six months ended June 30, 2017 we experienced a shortfall tax expense related to stock-based compensation of $0.9 million that increased the effective rate by 23%.
The $11.7 million of deferred revenue recorded during the six months ended June 30, 2018 is comprised primarily of the annual renewals of certain software subscriptions billed during the first quarter of each year and deposits collected for future EHR installations.Net cash provided by operating activities decreased $8.1 million, from $15.9 million provided by operations for the six months ended June 30, 2017 to $7.8 million provided by operations for the six months ended June 30, 2018.
Post-acute Care EHR bookings in the second quarter 2018 decreased $0.1 million, or 6%, compared to the second quarter 2017, and decreased $1.3 million, or 41%, compared to the six months ended June 30, 2017.
As a percentage of total revenues, total operating expenses increased to 48% in the second quarter 2018, compared to 47% in the second quarter 2017.
Total revenues for the three months ended June 30, 2018 increased slightly $0.2 million, compared to the three months ended June 30, 2017.
As a percentage of total revenues, costs of sales decreased to 47% in the six months ended June 30, 2018, compared to 48% in the six months ended June 30, 2017.
As a percentage of total revenues, costs of sales increased to 49% in the second quarter 2018, compared to 47% in the second quarter 2017.
Net income represented less than 1% of revenue for the three months ended June 30, 2018, compared to 2% of revenue for the three months ended June 30, 2017.
The gross margin on Post-acute Care EHR system sales and support increased to 72% in the second quarter 2018, compared to 67% in the second quarter 2017.
Our net income for the six months ended June 30, 2018 increased by $2.5 million to $4.3 million from the six months ended June 30, 2017 as a result of revenue growth accompanied with improved gross margins of 53%, a 1% increase from the first six months of 2017.
Total revenues for the six months ended June 30, 2018 increased 5%, or $7.0 million, compared to the six months ended June 30, 2017.None.Item 1.Legal Proceedings.